13 October 2015 - 15 October 2015
London, UK
Now in its third year, this international interdisciplinary event is an open forum for discussion of all scientific and clinical aspects of vaccine development and vaccinations. Using a multi-professional and inter-specialty approach this event offers plenty of opportunity for networking and debate, and will bring you up to date with current research and thinking.
This event has an open abstract session.
Abstracts can be submitted on any subject related to vaccines and vaccination
The Deadline for abstract submissions for oral presentation is July 20th 2015
Abstracts for poster presentation only can be submitted up to two weeks before the event
You can download the instructions for authors at www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
The Deadline for abstract submissions for oral presentation is July 20th 2015
Abstracts for poster presentation only can be submitted up to two weeks before the event
You can download the instructions for authors at www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
This event has CPD accreditation
A late registration fee applies after August 20th 2015
Tags: Active Heymann Nephritis (HN), Adeno virus, adjuvant, adjuvant delivery system, Angiotensin, Anti-vaccine forces, antiretroviral, Antiretrovirals, antivirals, bacteria, biodistribution, Cancer, Cancer risk, CD40, CD8+ T cells, Chronic hepatitis B, co-infections, DEC205, delivery, DNA vaccination, Edible vaccines, Emerging viruses, endoprotease, envelope, equine, Feline, FeLV, FIV, flagellin, gentic adjuvants, glycolipids, health care delivery, HIV, HIV-1, HIV/AIDS, Immune therapy, immunity, immunodeficiency, immunology, Immunosuppression, inflammation, Influenza, Innovative treatment, interprofessional collaboration, jaagsiekte, liposomes, lyophilisation, lyssaviruses, malaria vaccine, Medicinal Chemistry, Microbiology, microneedles, microparticulates, Nanotechnology, needle-free delivery, neutralisation assay, neutralising antibodies, neutralization, neutralization assays, neutralizing antibodies, neutralizing antibody, nicotine vaccine, oncogenic viruses, pandemic preparedness, Pharmaceutical Sciences, protein conformation and immunogenicity, Protein nanoparticles, pseudotype, pseudotypes, psudoviruses, public policy, rabies, rabies immunoglobulins, Rabies virus, Resistance, Retroviral pseudotype, retroviral pseudotypes, retrovirus, ruminant, safet, sero-surveillance, serological assays, serology, sheep, sheep retrovirus jaagsiekte ruminant serology, solid organ transplantation, SRH, stable packaging, sub-unit proteins, subunit vaccines, sugar antigen, susceptiblity, therapeutic, therapeutic vaccines, Therapuetic vaccine, Tissue Stress, TLR5, TLRs, Vaccine, Vaccine delivery, vaccine delivery systems, vaccine effectiveness, vaccine safety, Vaccines, virus, virus serology, virus tropism, zoonotic emerging viruses
Follow Us!